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SERINE PROTEASE PRSS11/HtrA1 DYSREGULATES 
AGGRECAN METABOLISM IN HUMAN ARTICULAR 
CARTILAGE 
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Pittman 3, V Daesety 1 , A Bermis 2, J Wu 2, Y Qiu 2, EA Morris 1 , C 
Flannery 1 
1 Women's Health and Musculoskeletal Biology, Wyeth 
Research, Cambridge, MA; 2Biological Technologies, Wyeth 
Research, Cambridge, MA; 3Cardiovascular and Metabolic 
Diseases, Wyeth Research, Cambridge, MA 
Aim: To investigate metabolic onsequences of PRSS11 expres- 
sion in human articular cartilage. 
Methods: Transcriptional profiling and mass spectrometry-based 
proteomic analyses were performed on human osteoarthritic ar- 
ticular cartilage specimens to identify altered gene expression as- 
sociated with osteoarthritis (OA). To further investigate the role 
of one such protein product, PRSS11, human chondrocyte cul- 
tures were infected with adenoviral constructs encoding active 
PRSS11 protease ora PRSS11 active site mutant (ASM; $328A). 
Human chondrocyte cultures were also exposed to PRSS11 ag- 
onist peptide CPII/III, which comprises the C-terminal 6-amino 
acid sequence present on the C-propeptides of collagens II 
and III, and which binds to the PDZ domain of PRSS11 with 
high affinity. Proteoglycan (aggrecan) content was monitored by 
DMMB assay. Quantification of mRNAs for aggrecan, ADAMTS- 
4 (aggrecanase-1) and ADAMTS-5 (aggrecanase-2) was per- 
formed by real-time RT-PCR (ABI PRISM). 
Results: Adenoviral overexpression of active PRSS11 resulted 
in significant reduction of aggrecan content (90-100%) in human 
chondrocyte-alginate cultures, whereas the PRSS11 ASM had 
no such effect. Expression of full-length PRSS11 at a lower level 
(using a different adenoviral vector) also significantly inhibited ag- 
grecan synthesis, but to a lesser extent, and inclusion of CPII/III 
agonist peptide in such cultures further enhanced the inhibitory 
effects of PRSS11. Non-infected human chondrocytes (which ex- 
press endogenous PRSS11) exposed to CPII/III agonist peptide 
displayed reduced expression of aggrecan mRNA, with concomi- 
tant upregulation of mRNAs for ADAMTS-4 and ADAMTS-5. 
Conclusions: Expression of PRSS11 in human chondrocytes 
may lead to a 'catabolic' phenotype, potentially via its docu- 
mented ability to antagonize TGFI~ family proteins. In addition, 
PRSS11 activity may be potentiated through PDZ domain interac- 
tions with agonist peptides uch as CPII/III. Elevated levels of col- 
lagen II C-propeptide in human articular cartilage are observed in 
association with OA as a result of increased collagen synthesis, 
and this may contribute to part of a 'feedback' mechanism to pro- 
mote disease progression. 
P300 
EVIDENCE FOR JNK-DEPENDENT UP-REGULATION OF 
PROTEOGLYCAN SYNTHESIS AND I~I-INTEGRIN- 
DEPENDENT ACTIVATION OF JNK1 FOLLOWING 
CYCLICAL MECHANICAL STIMULATION IN A HUMAN 
CHONDROCYTE CULTURE MODEL 
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Aims: To investigate whether following cyclical mechanical stim- 
ulation (MS), which up-regulates proteoglycan (PG) synthesis 
as shown in our previous studies, involves selective activation 
of mitogen-activated protein kinases (MAPKs) and to examine 
whether MS is associated with integrin-dependent or indepen- 
dent activation of MAPKs using human chondrocyte cell lines as 
a model. 
Methods: The C-28/12 and C-20/A4 human chondrocyte cell 
lines were mechanically stimulated for 0.5, 1, 2, and 3 hours at 
0.33 Hz, 30,700 i~strain, in monolayer cell culture. PG synthesis 
was assessed by [35S]-sulphate incorporation in the absence or 
presence of the p38 inhibitor SB203580 or the ERK1/2 inhibitor 
PD98059. Kinase expression and activation were assessed by 
Western blotting using phosphorylation status-dependent and 
independent antibodies also in the absence or presence of 
SB203580 and PD98059, and by kinase assays. The JNK in- 
hibitor SP600125 and the function-blocking antibody, CD 29, 
were used to assess JNK activation and integrin dependence re- 
spectively. 
Results: Increased PG synthesis following 3 hours of cyclic MS 
was abolished by pretreatment with 10 I~M SB203580, but was 
not affected by 50 I~M PD98059. The kinases ERK1/ERK2, p38 
and JNK were expressed in both stimulated and un-stimulated 
cells. The phosphorylation of 54 kDa and 48 kDa JNKs increased 
following 05, 1,2 and 3 hours of MS while the 46 kDa JNK protein, 
which was phosphorylated in un-stimulated cells, was dephos- 
phorylated after 1 and 2 hours MS, returning to the basal levels 
following 3 hours of MS. Phosphorylated p38 was not detected 
and phosphorylated ERK1 and ERK2 were unaffected by MS. 
JNK phosphorylation induced by MS was blocked by SB203580 
at 10 I~M or greater and activation of JNK following MS was 
blocked by the SP600125 inhibitor (_>101~M) and partially inhib- 
ited by the anti-I~l integrin blocking antibody. 
Conclusions: These data demonstrate that selective activation 
of JNK following clyclical MS in human chondrocyte cell lines is 
partially integrin dependent and suggest a mechanism for the in- 
creases in proteoglycan synthesis reported previously. 
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GLUCOSAMINE SULFATE INHIBITS EARLY RESPONSE 
GENES EXPRESSION INDUCED BY IL-ll~ IN A HUMAN 
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Aim of Study: Glucosamine sulfate (GS) was reported to inhibit 
IL-11~-induced expression of genes involved in inflammation and 
cartilage matrix degradation. The purpose of the present study 
was to investigate in a validated chondrocyte model whether GS 
also modulates the cytokine-stimulated expression of early re- 
sponse genes, including NFkB (Rel A, Rel B, NFkB1, NFkB2)and 
AP-1 (June B) family members, as well as EGR-1 that is also an 
upstream regulator of cell proliferation, differentation and apopto- 
sis. 
Methods: Confluent human chondrosarcoma cells SW1353 were 
pretreated for 1 hour with GS 10 I~M, i.e. close to the average 
peak glucosamine concentration found in plasma after oral ad- 
ministration of the full once-daily therapeutic dose, or with 0.1 I~M, 
i.e. a 100-fold lower concentration. Cultures were then stimulated 
with IL-11~ either 2 or 10 ng/ml. RealTime PCR analysis was used 
to quantify gene expression levels after appropriate time expo- 
sure to the stimulus (i.e. 1 hour for JunB/EGR-1 and 2 hours for 
NF-kB family members). All experiments were performed three 
times. 
Results: I1-11~ markedly increased the expression of the above 
mentioned genes, RelA being induced to a lesser extent. Pre- 
treatment with GS consistently induced a marked reduction in the 
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expression of the analyzed genes with comparable results in all 
experiments in a concentration dependent fashion. Results from 
a representative xperiment are reported in the table and are ex- 
pressed as % inhibition vs IL-11~ stimulation. 
% inhibition 
IL-lb 2 ng/ml IL-lb 10 ng/ml 
NFkB1 GS 0,1 mM -23 -40 
GS 10 mM -115 -85 
NFkB2 GS 0,1 mM -36 -62 
GS 10 mM -104 -102 
Rel A GS 0,1 mM -15 -42 
GS 10 mM -94 -106 
Rel B GS 0,1 mM -32 -54 
GS 10 mM -85 -92 
Jun B GS 0,1 mM -39 -25 
GS 10 mM -76 -70 
EGR-1 GS 0,1 mM -20 -11 
GS 10 mM -73 -89 
Conclusions: In a human chondrocyte-like cell model, therapeu- 
tically relevant concentrations of GS inhibited IL-11~-stimulated 
expression of early response genes including NFkB and AP-1 
family members, and EGR-1. Since these transcription factors in 
turn regulate the expression of several pro-inflammatory and pro- 
degenerative genes, GS favorable effects in this respect might 
be initiated by the previously reported inhibition of transcription 
factors activation and sustained thereafter by the presently de- 
scribed inhibition of their expression. In addition, the decrease 
in EGR-1 overexpression may limit cytokine-induced cell growth 
dysregulation. 
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COMPARATIVE EFFECTS OF TWO ANTIOXIDANTS, 
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Aim: To determine the effects of selenomethionine and epigallo- 
catechin gallate on gene expression, activation of mitogen acti- 
vating kinases and DNA-binding of NF-KB and AP-1 in articular 
chondrocytes. 
Methods: Chondrocytes, cultured in low-oxygen tension, were 
pre-treated with L-selenomethionine or EGCg for 24 h, followed 
by IL-11~ for further 1 h (nuclear and cytoplasmic extracts) or 24 
h (RNA extraction). RT-PCR was performed to determine mRNA 
levels of MMPs (-1, -3, -13), aggrecanases (-1, -2), interleukin-11~, 
inducible nitric oxide synthase, cyclooxygenases (-1, -2), type II 
collagen and aggrecan, transforming growth factor-I~ (-1, -2, -3) 
and their receptors I and II. Activity of mitogen-activating protein 
kinases was assayed by Western-blotting and AP-1/NF-KB DNA- 
binding by electrophoretic mobility shift assay. 
Results: Pre-treatment with 0.5 I~M Se-met prevented IL-11~- 
induced MMP-1 and aggrecanase-1 expression, and reduced the 
cytokine inhibitory effect of on type II collagen, aggrecan core pro- 
tein, and TI~RII mRNA levels. EGCg was more efficient in modu- 
lating the IL-11~ effects on the genes studied. Whereas EGCg in- 
hibited the IL-11~-activated MAPK, NF-KB and AP-1, Se-met stim- 
ulated that signaling pathway. This could account for the differen- 
tial effects exerted by these antioxidants on chondrocytes. 
Conclusions: The data provide insights into the mechanisms 
whereby epigallocatechin gallate and selenium modulate chon- 
drocyte metabolism. Despite their differential mechanisms of ac- 
tion, the two compounds could exert global beneficial effect on 
articular cartilage. 
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RHEIN, THE METABOLITE OF DIACERHEIN, MODULATES 
CELL SIGNALING AND GENE EXPRESSION OF 
ARTICULAR CHONDROCYTES CULTURED IN HYPOXIA 
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Aim: To determine the effect of pharmacologically relevant con- 
centrations of rhein, the metabolite of diacerhein, on signaling 
pathways and expression of genes related to catabolism or an- 
abolism of extracellular matrix of bovine articular chondrocytes 
cultured in low oxygen tension and exposed to interleukin-1 (IL- 
l). 
Methods: Bovine articular chondrocytes were isolated by en- 
zymatic procedure and cultured as monolayers in DMEM+10% 
FCS, either at normal atmosphere (21% 02) or in hypoxia (3% 
02). They were treated or not with IL-11~ (10 ng/ml) and rhein (10- 
4-10-5M, Negma Laboratories, Paris). At the end of experiments, 
cytoplasmic extracts were prepared and used in Western-blotting 
to detect ERK1/2, Jun and p38 kinases. Nuclear proteins were 
also extracted and subjected to EMSA analysis of NF-KB and AP- 
1 DNA binding. Total RNA was isolated and reverse transcribed to 
cDNA, which was then subjected to the relative quantitative real- 
time PCR (Q-RT-PCR) procedure, using the ABI PRISM 7000 and 
SYBR green detection and specific primers for type II collagen, 
aggrecan core protein, MMP-1, -3, -13, aggrecanases 1 and 2. 
RT-PCR data were normalized with 18S RNA and gene expres- 
sion relative to control was calculated with the delta delta cycle to 
threshold (ddCt) method. 
Results: Chondrocytes in hypoxia respond to I L-11~ (10 ng/ml) 
by an increased DNA binding activity of NF-KB and AP-1 tran- 
scription factors. Incubation with 10-5 M rhein for 24 h was found 
to reduce this activity. IL-11~-induced ERK-1 and ERK-2 activity 
was greater in hypoxia than in normoxia. Rhein was capable of 
reducing this effect, whatever the oxygen level. In contrast, no 
significant effect of the drug on the activity of p38 kinase was ob- 
served. Rhein was also found to decrease the IL-1 induced Jun 
kinase activation. 
The mRNA levels of type II collagen and aggrecan core protein 
were increased by a 24-h treatment with 10-5 M rhein. This ef- 
fect was also observed in the presence of IL-11~, indicating that 
the drug could prevent or reduce the IL-11~-induced inhibition of 
matrix synthesis. IL-1-induced expression of most degrading en- 
zymes (MMP-1, -3, -13, aggrecanase 1 ) was significantly reduced 
by rhein in the same conditions, except for aggrecanase 2. 
Conclusions: Rhein can inhibit the IL-l-activated MAPK path- 
way and the DNA binding of NF-KB and AP-1, two key factors 
involved in the expression of several pro-inflammatory genes by 
chondrocytes. The drug also reduces the procatabolic effect of 
the cytokine, by reducing the synthesis of most degrading en- 
zymes, and enhances the synthesis of cartilage specific compo- 
nents, such as type II collagen and aggrecan. These effects may 
explain the anti-osteoarthritic properties of rhein and its disease- 
modifying effects on OA cartilage. 
